The Enhanced Liver Fibrosis (ELF) Panel: Analyte Stability Under Common Sample Storage Conditions Used in Clinical Practice.

BACKGROUND The enhanced liver fibrosis (ELF) blood test has recently been recommended by the National Institute for Health and Care Excellence to test for advanced fibrosis in nonalcoholic fatty liver disease. The ELF test involves calculating a score from the concentrations of serum biomarkers: tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), aminoterminal propeptide of procollagen type III (P3NP), and hyaluronic acid (HA). Blood samples for the ELF score are often acquired in primary care and may be stored before analysis. However, the effect of preanalytical storage on the ELF test is not known. METHODS We conducted experiments to assess the stabilities of the ELF score, P3NP, HA, and TIMP-1 under medium- to long-term storage at -80 °C, repeated freeze-thawing, and refrigeration at 4 °C for days. RESULTS Mean TIMP-1 concentrations increased during medium- to long-term storage (+16.5%) and refrigeration (+4.9%), but were stable during freeze-thawing. Mean P3NP concentrations were stable under medium- to long-term storage, but increased during refrigeration (+7.4%) and freeze-thawing (+9.3%). Mean HA concentrations decreased during medium- to long-term storage (-12.3%) but were stable during refrigeration and freeze-thawing. Despite changes in biomarker concentrations, the changes in the mean ELF score were not clinically significant and not >0.1 U (0.7%). CONCLUSIONS The ELF score was stable, with no clinically significant changes under common storage conditions. These findings demonstrate that the ELF score is robust in situations where analysis may be delayed.

[1]  Shine-Young Kim,et al.  Effect of Repeated Freezing and Thawing on Biomarker Stability in Plasma and Serum Samples , 2015, Osong public health and research perspectives.

[2]  G. Yılmaz,et al.  Diagnostic potential of serum direct markers and non‐invasive fibrosis models in patients with chronic hepatitis B , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  P. Sönksen,et al.  The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes. , 2012, Drug testing and analysis.

[4]  G. Alexander,et al.  Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease , 2010, Gut.

[5]  R. Doss,et al.  Dependence of TIMP-1 Plasma Levels on Preanalytical Specimen Handling , 2008, Tumor Biology.

[6]  A. fong,et al.  Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[7]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[8]  D. Schuppan,et al.  Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.

[9]  H. Nielsen,et al.  Evaluation of Sample Handling in Relation to Levels of Tissue Inhibitor of Metalloproteinases-1 Measured in Blood by Immunoassay , 2003, The International journal of biological markers.

[10]  J. Beaudeux,et al.  Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[11]  F. Laine,et al.  Comparison of blood tests for liver fibrosis specific or not to NAFLD. , 2009, Journal of hepatology.

[12]  W. Rosenberg,et al.  Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. , 2009, Gastroenterology.

[13]  S. Friedman,et al.  Liver fibrosis -- from bench to bedside. , 2003, Journal of hepatology.

[14]  P. Bedossa,et al.  Fibrosis in Patients with Chronic Hepatitis C: Detection and Significance , 2000, Seminars in liver disease.

[15]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.